EP2915537A3 - Traitement de maladies inflammatoires au moyen de cellules souches placentaires - Google Patents
Traitement de maladies inflammatoires au moyen de cellules souches placentaires Download PDFInfo
- Publication number
- EP2915537A3 EP2915537A3 EP14193036.2A EP14193036A EP2915537A3 EP 2915537 A3 EP2915537 A3 EP 2915537A3 EP 14193036 A EP14193036 A EP 14193036A EP 2915537 A3 EP2915537 A3 EP 2915537A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- stem cells
- placental stem
- treatment
- inflammatory diseases
- scleroderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Insects & Arthropods (AREA)
- Wood Science & Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Husbandry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16166462.8A EP3103462A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP20177748.9A EP3763376A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90106707P | 2007-02-12 | 2007-02-12 | |
EP13178020.7A EP2687220A3 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP08725458.7A EP2120977B1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP13162384.5A EP2630959A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
Related Parent Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13162384.5A Division EP2630959A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP08725458.7A Division EP2120977B1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP13178020.7A Division EP2687220A3 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16166462.8A Division EP3103462A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP20177748.9A Division EP3763376A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2915537A2 EP2915537A2 (fr) | 2015-09-09 |
EP2915537A3 true EP2915537A3 (fr) | 2015-10-28 |
Family
ID=39618996
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08725458.7A Active EP2120977B1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP13178020.7A Withdrawn EP2687220A3 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP13162384.5A Withdrawn EP2630959A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP16166462.8A Ceased EP3103462A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP20177748.9A Withdrawn EP3763376A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP14193036.2A Withdrawn EP2915537A3 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08725458.7A Active EP2120977B1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP13178020.7A Withdrawn EP2687220A3 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP13162384.5A Withdrawn EP2630959A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP16166462.8A Ceased EP3103462A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
EP20177748.9A Withdrawn EP3763376A1 (fr) | 2007-02-12 | 2008-02-12 | Traitement de maladies inflammatoires au moyen de cellules souches placentaires |
Country Status (22)
Country | Link |
---|---|
US (7) | US8460650B2 (fr) |
EP (6) | EP2120977B1 (fr) |
JP (2) | JP5979811B2 (fr) |
KR (2) | KR20150039214A (fr) |
CN (3) | CN101657206B (fr) |
AU (1) | AU2008216749B2 (fr) |
CA (1) | CA2677397C (fr) |
CY (1) | CY1114301T1 (fr) |
DK (1) | DK2120977T3 (fr) |
ES (1) | ES2425181T3 (fr) |
HK (2) | HK1135328A1 (fr) |
HR (1) | HRP20130765T1 (fr) |
IL (5) | IL200338A (fr) |
ME (1) | ME01562B (fr) |
MX (2) | MX2009008563A (fr) |
NZ (3) | NZ578819A (fr) |
PL (1) | PL2120977T3 (fr) |
PT (1) | PT2120977E (fr) |
RS (1) | RS52921B (fr) |
SI (1) | SI2120977T1 (fr) |
WO (1) | WO2008100498A2 (fr) |
ZA (2) | ZA200905376B (fr) |
Families Citing this family (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8147824B2 (en) | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
KR100915482B1 (ko) | 2000-12-06 | 2009-09-03 | 하리리 로버트 제이 | 태반 줄기 세포의 회수 방법 |
MX348185B (es) | 2001-02-14 | 2017-06-02 | Anthrogenesis Corp | Placenta de mamíferos postparto, su uso y células madres placentales extraídas de ella. |
US7498171B2 (en) | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
JP2006509770A (ja) * | 2002-11-26 | 2006-03-23 | アンソロジェネシス コーポレーション | 細胞治療学、細胞治療単位、およびそれらを利用した治療法 |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
JP4950660B2 (ja) * | 2003-06-27 | 2012-06-13 | エチコン、インコーポレイテッド | 分娩後由来細胞を使用する眼組織の修復および再生 |
WO2005097190A2 (fr) * | 2004-03-26 | 2005-10-20 | Celgene Corporation | Systemes et procedes pour produire une banque de cellules souches |
PL1831356T3 (pl) | 2004-12-23 | 2017-07-31 | DePuy Synthes Products, Inc. | Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania |
NZ597304A (en) | 2005-10-13 | 2013-06-28 | Anthrogenesis Corp | Immunomodulation using placental stem cells |
US8071376B2 (en) * | 2005-10-13 | 2011-12-06 | Anthrogenesis Corporation | Production of oligodendrocytes from placenta-derived stem cells |
US10117900B2 (en) | 2005-11-09 | 2018-11-06 | Athersys, Inc. | MAPC treatment of brain injuries and diseases |
US11000546B2 (en) | 2005-11-09 | 2021-05-11 | Athersys, Inc. | Immunomodulatory properties of MAPCs and uses thereof |
PL1971681T3 (pl) | 2005-12-16 | 2018-01-31 | Depuy Synthes Products Inc | Kompozycje oraz sposoby do hamowania niepożądanej odpowiedzi immunologicznej w przypadku transplantacji z brakiem zgodności tkankowej |
ZA200804718B (en) * | 2005-12-29 | 2010-04-28 | Anthrogenesis Corp | Co-culture of placental stem cells and stem cells from a second source |
EP1976977B1 (fr) | 2005-12-29 | 2015-07-08 | Anthrogenesis Corporation | Populations de cellules souches placentaires |
CN101374941A (zh) * | 2005-12-29 | 2009-02-25 | 人类起源公司 | 采集和保存胎盘干细胞的改良组合物及其使用方法 |
CN101410125A (zh) | 2006-01-23 | 2009-04-15 | 阿特西斯公司 | 脑损伤和疾病的mapc治疗 |
US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
US8562972B2 (en) | 2006-10-23 | 2013-10-22 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
EP2118267B1 (fr) | 2007-01-17 | 2017-03-15 | Noveome Biotherapeutics, Inc. | Nouveaux procédés pour moduler des réponses inflammatoires et/ou immunitaires |
CN101657206B (zh) * | 2007-02-12 | 2013-07-03 | 人类起源公司 | 利用胎盘干细胞治疗炎性疾病 |
CN101688177A (zh) | 2007-02-12 | 2010-03-31 | 人类起源公司 | 来自贴壁胎盘干细胞的肝细胞和软骨细胞;以及cd34+、cd45-胎盘干细胞富集的细胞群 |
JP5597129B2 (ja) | 2007-06-18 | 2014-10-01 | チルドレンズ ホスピタル アンド リサーチ センター アット オークランド | 胎盤由来の幹細胞および前駆体細胞の単離方法 |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
SI2200622T2 (sl) | 2007-09-19 | 2015-09-30 | Pluristem Ltd. | Adherentne celice iz adipoznih ali placentnih tkiv in njihova uporaba pri terapiji |
CN101878034B (zh) | 2007-09-28 | 2013-11-20 | 细胞基因细胞疗法公司 | 使用人胎盘灌洗液和人来自胎盘的中间体自然杀伤细胞的肿瘤抑制 |
CN102123717A (zh) | 2008-05-27 | 2011-07-13 | 普拉里斯坦有限公司 | 治疗炎性结肠疾病的方法 |
CA2734237C (fr) | 2008-08-20 | 2019-07-02 | Anthrogenesis Corporation | Traitement d'un accident vasculaire cerebral a l'aide de cellules placentaires isolees |
KR20200011604A (ko) | 2008-08-20 | 2020-02-03 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
AU2009283161A1 (en) | 2008-08-22 | 2010-02-25 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
EP2334783B1 (fr) | 2008-09-02 | 2016-06-22 | Pluristem Ltd. | Cellules adhérentes provenant d'un tissu placentaire et leur utilisation en thérapie |
US9096827B2 (en) * | 2008-09-02 | 2015-08-04 | Pluristem Ltd. | Adherent cells from placenta tissue and use thereof in therapy |
WO2010042716A1 (fr) * | 2008-10-08 | 2010-04-15 | The Children's Hospital Of Philadelphia | Altérations génétiques associées au diabète de type i et procédés d'utilisation de celles-ci pour un diagnostic et un traitement |
US8367409B2 (en) | 2008-11-19 | 2013-02-05 | Anthrogenesis Corporation | Amnion derived adherent cells |
AU2009316376B2 (en) * | 2008-11-21 | 2015-08-20 | Celularity Inc. | Treatment of diseases, disorders or conditions of the lung using placental cells |
ES2665883T3 (es) * | 2008-12-19 | 2018-04-30 | DePuy Synthes Products, Inc. | Tratamiento de enfermedades y trastornos pulmonares y pulmonares |
AU2009327382B2 (en) * | 2008-12-19 | 2014-07-17 | DePuy Synthes Products, LLC | Umbilical cord tissue derived cells for treating neuropathic pain and spasticity |
US8771677B2 (en) | 2008-12-29 | 2014-07-08 | Vladimir B Serikov | Colony-forming unit cell of human chorion and method to obtain and use thereof |
EP2377542A4 (fr) * | 2009-01-15 | 2013-04-03 | Corestem Co Ltd | Composition pharmaceutique pour traiter des maladies osseuses ou contrer une inflammation, comprenant des cellules souches de cartilage en tant que principe actif |
NZ595440A (en) * | 2009-03-25 | 2014-05-30 | Anthrogenesis Corp | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
BRPI1013409A2 (pt) | 2009-03-26 | 2018-01-16 | Advanced Tech And Regenerative Medicine Llc | células de tecido de cordão umbilical humano como terapia para doença de alzheimer |
US8796315B2 (en) | 2009-06-25 | 2014-08-05 | Darlene E. McCord | Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells |
AR077369A1 (es) | 2009-07-02 | 2011-08-24 | Anthrogenesis Corp | Metodopara producir eritrocitos sin celulas alimentadoras |
US8647617B2 (en) | 2009-07-13 | 2014-02-11 | Stemnion, Inc. | Methods for modulating inflammatory and/or immune responses |
EP2507362A2 (fr) * | 2009-11-30 | 2012-10-10 | Pluristem Ltd. | Cellules adhérentes du placenta et leur utilisation dans le traitement de pathologies |
CN102822330A (zh) | 2010-01-26 | 2012-12-12 | 人类起源公司 | 使用胎盘干细胞对骨相关癌的治疗 |
AR080221A1 (es) * | 2010-02-18 | 2012-03-21 | Osiris Therapeutics Inc | Productos de membranas amnioticas inmunocompatibles |
SI2556145T1 (sl) | 2010-04-07 | 2017-01-31 | Anthrogenesis Corporation | Angiogeneza z uporabo placentnih matičnih celic |
WO2011127113A1 (fr) * | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Traitement de la sarcoïdose au moyen de cellules souches du sang placentaire |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
LT2576768T (lt) | 2010-06-01 | 2017-08-25 | Auxocell Laboratories, Inc. | Gamtinės wharton`s jelly kamieninės ląstelės ir jų gryninimas |
WO2012009422A1 (fr) | 2010-07-13 | 2012-01-19 | Anthrogenesis Corporation | Procédés de génération de cellules tueuses naturelles |
ES2599331T3 (es) * | 2010-12-17 | 2017-02-01 | Anthrogenesis Corporation | Tratamiento de enfermedades y trastornos relacionados con el sistema inmunitario usando células adherentes derivadas del amnios |
MX2013006595A (es) * | 2010-12-17 | 2014-04-07 | Anthrogenesis Corp | Tratamiento de lesion de la medula espinal y lesion traumatica del cerebro empleando celulas madre placentarias. |
US8574899B2 (en) | 2010-12-22 | 2013-11-05 | Vladimir B Serikov | Methods for augmentation collection of placental hematopoietic stem cells and uses thereof |
WO2012092458A2 (fr) | 2010-12-30 | 2012-07-05 | Anthrogenesis Corporation | Compositions contenant des cellules souches placentaires et du plasma riche en plaquettes, et leurs méthodes d'utilisation |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
US8709401B2 (en) * | 2011-02-25 | 2014-04-29 | Howmedica Osteonics Corp. | Primed stem cells and uses thereof to treat inflammatory conditions in joints |
EP2689008B1 (fr) | 2011-03-22 | 2017-09-27 | Pluristem Ltd. | Procédés de traitement de blessures dues aux expositions aux irradiations ou aux produits chimiques |
US20140127741A1 (en) * | 2011-04-13 | 2014-05-08 | Biocell Center S.P.A. | Method of collection, classification and preservation of samples containing stem cells |
CN103619177A (zh) * | 2011-04-25 | 2014-03-05 | 南加州大学 | 通过抑制干扰素-γ和肿瘤坏死因子-α来改善组织再生的方法和组合物 |
CN113559126A (zh) * | 2011-06-01 | 2021-10-29 | 人类起源公司 | 利用胎盘干细胞治疗疼痛 |
WO2013055476A1 (fr) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Traitement de la sclérose latérale amyotrophique au moyen de cellules souches placentaires |
ITTO20111183A1 (it) | 2011-12-21 | 2013-06-22 | Univ Degli Studi Torino | Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia |
CN103185778B (zh) * | 2011-12-30 | 2015-03-18 | 深圳市亚辉龙生物科技有限公司 | 一种检测抗Scl70抗体的试剂装置及其方法 |
ES2656614T3 (es) * | 2011-12-30 | 2018-02-27 | Amit Patel | Métodos y composiciones para la derivación clínica de células alogénicas y sus usos terapéuticos |
US9575054B2 (en) | 2012-02-23 | 2017-02-21 | Anthrogenesis Corporation | Identification of antitumor compounds using placenta |
US8940294B2 (en) | 2012-03-02 | 2015-01-27 | Tissuetech, Inc. | Methods of isolating and culturing stem cells |
JP6901823B2 (ja) | 2012-08-01 | 2021-07-14 | ユナイテッド セラピューティクス コーポレイション | 間葉系幹細胞による肺動脈性高血圧症の処置 |
WO2014022376A2 (fr) | 2012-08-01 | 2014-02-06 | United Therapeutics Corporation | Traitement de l'hypertension artérielle pulmonaire avec des cellules progénitrices endothéliales traitées à la prostacycline |
RU2522972C2 (ru) * | 2012-08-27 | 2014-07-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации ". | Способ лечения хронических воспалительных заболеваний, сопровождающихся иммунодефицитными состояниями |
KR101532556B1 (ko) | 2012-09-03 | 2015-06-30 | 메디포스트(주) | 간엽줄기세포의 배양 방법 |
CN103040860B (zh) | 2012-11-29 | 2018-08-14 | 刘学武 | 一种启动哺乳动物干细胞的方法及二氧化氯在制备用于启动哺乳动物干细胞的药物的应用 |
US9144555B2 (en) | 2012-11-30 | 2015-09-29 | Darlene E. McCord | Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition |
EP3878452B1 (fr) | 2013-01-09 | 2023-09-20 | United Therapeutics Corporation | Traitement de la vasculopathie au moyen de la prostacycline et de cellules souches mésenchymateuses |
EP3622960A1 (fr) | 2013-02-05 | 2020-03-18 | Celularity, Inc. | Cellules tueuses naturelles placentaires |
JP6327647B2 (ja) * | 2013-02-13 | 2018-05-23 | 国立大学法人徳島大学 | 炎症性疾患の予防又は治療用組成物 |
ES2647494T3 (es) * | 2013-03-01 | 2017-12-21 | Apceth Gmbh & Co. Kg | Protección del endotelio vascular de las reacciones citotóxicas mediadas inmunológicamente con células progenitoras humanas cd34-negativo |
WO2014159826A1 (fr) * | 2013-03-14 | 2014-10-02 | Antrhogenesis Corporation | Utilisation de cellules souches placentaires dans le traitement d'une lésion rénale aiguë |
WO2014141111A1 (fr) * | 2013-03-14 | 2014-09-18 | Pluristem Ltd. | Méthode permettant de prévenir et de traiter la maladie du greffon contre l'hôte |
US10039792B1 (en) | 2013-03-16 | 2018-08-07 | Brahm Holdings, Llc | Methods for the treatment of inflammation and pain using human birth tissue material composition |
JP6512759B2 (ja) * | 2013-08-19 | 2019-05-15 | 国立研究開発法人国立循環器病研究センター | 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤 |
WO2015073786A1 (fr) * | 2013-11-15 | 2015-05-21 | Women And Infants Hospital Of Rhode Island | Procédés pour traiter ou prévenir un trouble pulmonaire |
CN103555664B (zh) * | 2013-11-19 | 2015-11-04 | 武汉道培胎盘干细胞生物技术有限公司 | 一种培养人胎盘间充质干细胞的方法 |
JP6474549B2 (ja) * | 2014-03-03 | 2019-02-27 | 国立大学法人徳島大学 | 幹細胞の培養産物の評価指標及びその利用 |
EP3137084B1 (fr) * | 2014-05-02 | 2019-12-25 | The Board of Trustees of the Leland Stanford Junior University | Amiloride de benzyle pour le traitement du psoriasis |
US10363278B2 (en) | 2014-06-15 | 2019-07-30 | Amnio Technology Llc | Frozen therapeutic dose and package |
US20160095307A1 (en) * | 2014-10-07 | 2016-04-07 | NuTech Medical, Inc. | Method and composition for hypothermic storage of placental tissue |
WO2016122661A1 (fr) | 2015-01-30 | 2016-08-04 | Hewlett-Packard Development Company, L.P. | Impression mobile |
US10531957B2 (en) | 2015-05-21 | 2020-01-14 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
IL255920B2 (en) * | 2015-05-28 | 2024-05-01 | Celularity Inc | Stem cells derived from the placenta and their use for the restoration of the regeneration engine, for the repair of protein defects for the extension of the useful life of aging items |
WO2017058838A1 (fr) * | 2015-09-29 | 2017-04-06 | Anthrogenesis Corporation | Test d'activité biologique cellulaire |
WO2017096347A1 (fr) * | 2015-12-04 | 2017-06-08 | Fred Hutchinson Cancer Research Center | Utilisations de populations étendues de cellules souches/progénitrices hématopoïétiques |
KR101901568B1 (ko) | 2016-07-04 | 2018-09-28 | 주식회사 강스템바이오텍 | 연골 무세포 파쇄물 및 줄기세포를 포함하는 연골분화 촉진용 복합체 및 그의 용도 |
EP3503933A1 (fr) | 2016-08-24 | 2019-07-03 | Arthrex, Inc. | Utilisation de tissu pour la réparation d'une lésion |
WO2018053233A1 (fr) * | 2016-09-15 | 2018-03-22 | Memorial Sloan Kettering Cancer Center | Inhibition du métabolisme de l'acétyl-coa pour le traitement et la prévention de maladies et de troubles du système immunitaire |
WO2018075433A1 (fr) * | 2016-10-18 | 2018-04-26 | StemBios Technologies, Inc. | Composition et méthode destinée à réduire le taux de bilirubine |
IL266175B2 (en) | 2016-10-24 | 2024-01-01 | United Therapeutics Corp | Enhancement of immunomodulatory properties of MSC using treprostinil |
WO2018092769A1 (fr) | 2016-11-15 | 2018-05-24 | 株式会社カネカ | Population de cellules contenant des cellules souches mésenchymateuses dérivées d'appendices fœtaux, son procédé de production, et composition médicinale |
EP4252629A3 (fr) | 2016-12-07 | 2023-12-27 | Biora Therapeutics, Inc. | Procédés, dispositifs et systèmes de détection du tractus gastro-intestinal |
WO2018183941A2 (fr) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Traitement d'une maladie du tractus gastro-intestinal avec un agent biothérapeutique vivant |
EP3704225B1 (fr) * | 2017-10-27 | 2023-10-11 | Alis Pharma Ltd. | Extrait de tissus foetaux, procédés de production de l'extrait et utilisation associée |
EP3750987A4 (fr) | 2017-12-28 | 2021-11-10 | Kaneka Corporation | Population cellulaire comprenant des cellules souches adhésives, son procédé de production, et composition pharmaceutique |
CN108089057B (zh) * | 2018-01-26 | 2019-09-17 | 吉林大学 | 一种用于超低温光电输运测试的测试平台 |
JP7446619B2 (ja) | 2018-04-09 | 2024-03-11 | セルリサーチ コーポレイション プライベート リミテッド | 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法 |
WO2019235853A1 (fr) * | 2018-06-05 | 2019-12-12 | 메디포스트(주) | Composition pharmaceutique comprenant de l'acide hyaluronique et des cellules souches permettant de traiter une maladie associée à des lésions du cartilage |
DE202018003814U1 (de) | 2018-08-19 | 2018-11-09 | Mohamed Shehata Ali Mohamed | Antipsoriatisches Gel für Hautanwendung II |
KR102159630B1 (ko) * | 2018-11-06 | 2020-09-24 | 차의과학대학교 산학협력단 | 태반-유래 중간엽 줄기세포를 포함하는 담즙정체성 간질환 또는 고지혈증의 예방 또는 치료용 약학 조성물 |
US11511017B2 (en) | 2019-03-12 | 2022-11-29 | Arthrex, Inc. | Ligament reconstruction |
CA3125311A1 (fr) * | 2019-03-27 | 2020-10-01 | Pluristem Ltd. | Procedes et compositions pour le traitement esthetique et cosmetique et la stimulation de la pousse des cheveux |
CA3138884A1 (fr) | 2019-05-06 | 2020-11-12 | Accelerated Biosciences Corp. | Cellules cytotrophoblastiques regulatrices et precurseurs et leurs utilisations |
WO2020251020A1 (fr) | 2019-06-14 | 2020-12-17 | 株式会社カネカ | Population de cellules comprenant des cellules mésenchymateuses, composition pharmaceutique la comprenant et son procédé de production |
KR20200000415A (ko) * | 2019-12-24 | 2020-01-02 | (주)안트로젠 | 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법 |
US20210283189A1 (en) * | 2020-03-12 | 2021-09-16 | Pluristem Ltd. | Methods and compositions for treating viral infections |
KR102340058B1 (ko) | 2020-05-12 | 2021-12-16 | 경북대학교 산학협력단 | 양막상피세포 유래 엑소좀을 유효성분으로 함유하는 안구질환 예방 또는 치료용 조성물 |
CN111821251B (zh) * | 2020-07-07 | 2022-06-14 | 北京清大赛尔生物科技有限公司 | 化妆品用组合物和化妆品 |
CN113827618B (zh) * | 2021-10-20 | 2023-09-26 | 上海交通大学医学院附属仁济医院 | 干细胞条件培养基在制备用于治疗炎症性皮肤的药物中的用途 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003068937A2 (fr) * | 2002-02-13 | 2003-08-21 | Anthrogenesis Corporation | Cellules souches de type embryonnaire derivees de placenta mammalien post-partum, utilisations, et procedes de traitement a base de cellules de ce type |
WO2006051538A2 (fr) * | 2004-11-10 | 2006-05-18 | Hadasit Medical Research Services And Development Ltd. | Cellules isolees a partir de plasma, dispositif d'isolation associe et leurs utilisations |
WO2007047468A2 (fr) * | 2005-10-13 | 2007-04-26 | Anthrogenesis Corporation | Immunomodulation realisee avec des cellules souches placentaires |
WO2007079183A2 (fr) * | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Populations de cellules souches placentaires |
WO2007108003A2 (fr) * | 2006-03-23 | 2007-09-27 | Pluristem Ltd. | Procedes de developpement cellulaire et utilisations therapeutiques des cellules et des milieux conditionnes produits de cette maniere |
WO2008036374A2 (fr) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogreffes de cellules souches chez des receveurs non conditionnes |
Family Cites Families (306)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862002A (en) * | 1962-05-08 | 1975-01-21 | Sanfar Lab Inc | Production of physiologically active placental substances |
US4060081A (en) | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
US4458678A (en) | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
US4520821A (en) | 1982-04-30 | 1985-06-04 | The Regents Of The University Of California | Growing of long-term biological tissue correction structures in vivo |
US4485097A (en) | 1982-05-26 | 1984-11-27 | Massachusetts Institute Of Technology | Bone-equivalent and method for preparation thereof |
US4829000A (en) | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
US4798824A (en) | 1985-10-03 | 1989-01-17 | Wisconsin Alumni Research Foundation | Perfusate for the preservation of organs |
US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5902741A (en) | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
NZ226750A (en) | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
US5004681B1 (en) | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
US5192553A (en) | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
GB8803697D0 (en) | 1988-02-17 | 1988-03-16 | Deltanine Research Ltd | Clinical developments using amniotic membrane cells |
US5284766A (en) * | 1989-02-10 | 1994-02-08 | Kao Corporation | Bed material for cell culture |
FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5437994A (en) | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5635386A (en) | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
US5763266A (en) | 1989-06-15 | 1998-06-09 | The Regents Of The University Of Michigan | Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
ATE423195T1 (de) | 1989-07-25 | 2009-03-15 | Cell Genesys Inc | Homologe rekombination für universelle donorzellen und chimerische säugetierzellen |
US5464764A (en) * | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
DE69032809T2 (de) | 1989-11-06 | 1999-07-08 | Cell Genesys Inc | Herstellung von Proteinen mittels homologer Rekombination |
US5272071A (en) | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5226914A (en) | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
US6010696A (en) | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
US5733542A (en) | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5192312A (en) * | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
US5190556A (en) | 1991-03-19 | 1993-03-02 | O.B. Tech, Inc. | Cord cutter sampler |
US5744361A (en) * | 1991-04-09 | 1998-04-28 | Indiana University | Expansion of human hematopoietic progenitor cells in a liquid medium |
WO1993004169A1 (fr) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Ciblage de genes dans des cellules animales au moyen de produits de synthese d'adn isogeniques |
US5356373A (en) | 1991-11-15 | 1994-10-18 | Miles Inc. | Method and apparatus for autologous transfusions in premature infants |
US6057123A (en) | 1991-12-23 | 2000-05-02 | British Biotech Pharmaceuticals Limited | Stem cell inhibiting proteins |
US6120735A (en) | 1992-02-26 | 2000-09-19 | The Ohio States University | Fractional cell sorter |
EP0590156A4 (en) | 1992-03-31 | 1994-07-13 | Toray Industries | Novel, physiologically active protein and hemopoietic stem cell growth promoter |
US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
US5552267A (en) | 1992-04-03 | 1996-09-03 | The Trustees Of Columbia University In The City Of New York | Solution for prolonged organ preservation |
WO1994000484A1 (fr) | 1992-06-22 | 1994-01-06 | Young Henry E | Facteur inhibiteur de cicatrices et utilisation |
US5672346A (en) | 1992-07-27 | 1997-09-30 | Indiana University Foundation | Human stem cell compositions and methods |
US5849553A (en) | 1992-07-27 | 1998-12-15 | California Institute Of Technology | Mammalian multipotent neural stem cells |
US5693482A (en) | 1992-07-27 | 1997-12-02 | California Institute Of Technology | Neural chest stem cell assay |
SG86980A1 (en) | 1992-11-16 | 2002-03-19 | Applied Immunesciences | Pluripotential quiescent stem cell population |
US5772992A (en) | 1992-11-24 | 1998-06-30 | G.D. Searle & Co. | Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors |
US5654186A (en) | 1993-02-26 | 1997-08-05 | The Picower Institute For Medical Research | Blood-borne mesenchymal cells |
AU694111B2 (en) * | 1993-03-31 | 1998-07-16 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
GB9308271D0 (en) | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5698579A (en) | 1993-07-02 | 1997-12-16 | Celgene Corporation | Cyclic amides |
US5372581A (en) | 1993-07-21 | 1994-12-13 | Minneapolis Children's Services Corporation | Method and apparatus for placental blood collection |
IL107483A0 (en) | 1993-11-03 | 1994-02-27 | Yeda Res & Dev | Bone marrow transplantation |
US5599705A (en) | 1993-11-16 | 1997-02-04 | Cameron; Robert B. | In vitro method for producing differentiated universally compatible mature human blood cells |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US6288030B1 (en) * | 1993-12-22 | 2001-09-11 | Amgen Inc. | Stem cell factor formulations and methods |
US6001654A (en) | 1994-01-28 | 1999-12-14 | California Institute Of Technology | Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
DE69531638T2 (de) * | 1994-06-06 | 2004-06-17 | Osiris Therapeutics, Inc. | Biomatrix für geweberegenaration |
US6174333B1 (en) * | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
DE4422667A1 (de) | 1994-06-30 | 1996-01-04 | Boehringer Ingelheim Int | Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen |
US6103522A (en) * | 1994-07-20 | 2000-08-15 | Fred Hutchinson Cancer Research Center | Human marrow stromal cell lines which sustain hematopoiesis |
US5516532A (en) | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
US5827742A (en) | 1994-09-01 | 1998-10-27 | Beth Israel Deaconess Medical Center, Inc. | Method of selecting pluripotent hematopioetic progenitor cells |
US5665557A (en) | 1994-11-14 | 1997-09-09 | Systemix, Inc. | Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof |
MX9701512A (es) * | 1994-11-16 | 1997-05-31 | Amgen Inc | Uso del factor de celulas madre y receptor de interleucina-6 soluble para la expansion ex vivo de celulas multipotenciales hematopoyeticas. |
US5874301A (en) | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5914268A (en) | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5789147A (en) | 1994-12-05 | 1998-08-04 | New York Blood Center, Inc. | Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
US6974571B2 (en) | 1995-03-28 | 2005-12-13 | Thomas Jefferson University | Isolated stromal cells and methods of using the same |
EP1304112B1 (fr) | 1995-03-28 | 2006-06-14 | Thomas Jefferson University | Implant comprenant des cellules de stroma immunologiquement solées et son utilisation |
US5716616A (en) * | 1995-03-28 | 1998-02-10 | Thomas Jefferson University | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
US5733541A (en) * | 1995-04-21 | 1998-03-31 | The Regent Of The University Of Michigan | Hematopoietic cells: compositions and methods |
WO1996034035A1 (fr) | 1995-04-27 | 1996-10-31 | The Procter & Gamble Company | Substrat support traite avec une emulsion inverse a haute teneur en phase aqueuse interne constituee d'un emulsifiant d'organopolysiloxane-polyoxyalkylene |
US5925567A (en) | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
US5908782A (en) | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
US5830708A (en) | 1995-06-06 | 1998-11-03 | Advanced Tissue Sciences, Inc. | Methods for production of a naturally secreted extracellular matrix |
WO1996040875A1 (fr) | 1995-06-07 | 1996-12-19 | Novartis Ag | Procedes d'obtention de compositions enrichies en cellules souches hematopoietiques et anticorps utilises a cet effet |
US6306575B1 (en) | 1995-06-16 | 2001-10-23 | Stemcell Technologies, Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US5654381A (en) | 1995-06-16 | 1997-08-05 | Massachusetts Institute Of Technology | Functionalized polyester graft copolymers |
US5877299A (en) * | 1995-06-16 | 1999-03-02 | Stemcell Technologies Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US5858782A (en) * | 1995-11-13 | 1999-01-12 | Regents Of The University Of Michigan | Functional human hematopoietic cells |
AU1119397A (en) | 1995-11-14 | 1997-06-05 | Regents Of The University Of Minnesota | Ex vivo culture of stem cells |
JP3781433B2 (ja) | 1995-11-16 | 2006-05-31 | ケース ウエスターン リザーブ ユニバーシティ | ヒト間葉幹細胞の試験管内軟骨形成誘導 |
EP0861894B1 (fr) * | 1995-11-17 | 2006-03-08 | Asahi Kasei Kabushiki Kaisha | Polypeptide suppresseur et de differenciation |
US5716794A (en) * | 1996-03-29 | 1998-02-10 | Xybernaut Corporation | Celiac antigen |
ES2329953T3 (es) * | 1996-04-19 | 2009-12-02 | Osiris Therapeutics, Inc. | Regeneracion e incremento de hueso utilizando celulas madre mesenquimales. |
JP2000508922A (ja) | 1996-04-26 | 2000-07-18 | ケース ウエスターン リザーブ ユニバーシティ | 間葉幹細胞を用いる皮膚再生 |
US5919176A (en) | 1996-05-14 | 1999-07-06 | Children's Hospital Medical Center Of Northern California | Apparatus and method for collecting blood from an umbilical cord |
US6281230B1 (en) | 1996-07-24 | 2001-08-28 | Celgene Corporation | Isoindolines, method of use, and pharmaceutical compositions |
US5635517B1 (en) | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
HU228769B1 (en) | 1996-07-24 | 2013-05-28 | Celgene Corp | Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha |
US5798368A (en) | 1996-08-22 | 1998-08-25 | Celgene Corporation | Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNFα levels |
US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
US6358737B1 (en) * | 1996-07-31 | 2002-03-19 | Board Of Regents, The University Of Texas System | Osteocyte cell lines |
EP0918746B1 (fr) | 1996-08-12 | 2003-04-09 | Celgene Corporation | Agents immunotherapiques et leur utilisation pour faire baisser les teneurs en cytokines |
US5851984A (en) | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
US5916202A (en) * | 1996-08-30 | 1999-06-29 | Haswell; John N. | Umbilical cord blood collection |
US6227202B1 (en) | 1996-09-03 | 2001-05-08 | Maulana Azad Medical College | Method of organogenesis and tissue regeneration/repair using surgical techniques |
US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
US5919702A (en) | 1996-10-23 | 1999-07-06 | Advanced Tissue Science, Inc. | Production of cartilage tissue using cells isolated from Wharton's jelly |
US5969105A (en) | 1996-10-25 | 1999-10-19 | Feng; Yiqing | Stem cell factor receptor agonists |
US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
US5968820A (en) | 1997-02-26 | 1999-10-19 | The Cleveland Clinic Foundation | Method for magnetically separating cells into fractionated flow streams |
US6152142A (en) | 1997-02-28 | 2000-11-28 | Tseng; Scheffer C. G. | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
US6231880B1 (en) | 1997-05-30 | 2001-05-15 | Susan P. Perrine | Compositions and administration of compositions for the treatment of blood disorders |
DE69837491T2 (de) | 1997-07-03 | 2008-01-17 | Osiris Therapeutics, Inc. | Menschliche mesenchymale stammzellen aus peripherem blut |
US7514074B2 (en) | 1997-07-14 | 2009-04-07 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
DE69831957T3 (de) | 1997-07-14 | 2009-07-23 | Osiris Therapeutics, Inc. | Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen |
US6077708A (en) | 1997-07-18 | 2000-06-20 | Collins; Paul C. | Method of determining progenitor cell content of a hematopoietic cell culture |
US5879318A (en) * | 1997-08-18 | 1999-03-09 | Npbi International B.V. | Method of and closed system for collecting and processing umbilical cord blood |
AU9127098A (en) * | 1997-09-04 | 1999-03-22 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
US6093531A (en) | 1997-09-29 | 2000-07-25 | Neurospheres Holdings Ltd. | Generation of hematopoietic cells from multipotent neural stem cells |
US5955476A (en) | 1997-11-18 | 1999-09-21 | Celgene Corporation | Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels |
US5874448A (en) * | 1997-11-18 | 1999-02-23 | Celgene Corporation | Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels |
US6248587B1 (en) | 1997-11-26 | 2001-06-19 | University Of Southern Cailfornia | Method for promoting mesenchymal stem and lineage-specific cell proliferation |
US6059968A (en) | 1998-01-20 | 2000-05-09 | Baxter International Inc. | Systems for processing and storing placenta/umbilical cord blood |
US6291240B1 (en) | 1998-01-29 | 2001-09-18 | Advanced Tissue Sciences, Inc. | Cells or tissues with increased protein factors and methods of making and using same |
BR9907852A (pt) * | 1998-02-12 | 2000-10-24 | Immunivest Corp | Processos para detectar e enumerar células raras e cancerosas em uma população celular mista, para diagnosticar câncer de estágio precoce em um paciente de teste, para determinar a probabilidade de recorrência de câncer em um paciente humano anteriormente tratado de câncer, para distinguir um carcinoma confinado ao órgão de um carcinoma com propriedades metastáticas, para acompanhar a situação de remissão em um paciente humano com câncer que passa pelo tratamento de terapia contra o câncer e para aumentar quantidades de células epiteliais circulantes em uma amostra de sangue, partìcula magnética revestida, composição, conjuntos de teste para avaliar uma amostra de paciente quanto a presença de células raras circulantes, quanto a presença de células de tumor circulantes, quanto a presença de células de câncer de mama circulantes, quanto a presença de células de câncer de próstata circulantes, quanto a presença de células de câncer de cólon circulantes, quanto a presença de células de câncer de bexiga circulantes e para monitorar um paciente quanto a recorrência de câncer, e, fração de sangue periférico enriquecido quanto a células neoplásticas circulantes |
ATE286118T1 (de) * | 1998-03-13 | 2005-01-15 | Osiris Therapeutics Inc | Anwendungen für humane nicht autologe, mesenchymale stammzellen |
HUP0102113A3 (en) | 1998-03-16 | 2003-03-28 | Celgene Corp Warren | 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
US6368636B1 (en) | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
AU755888B2 (en) | 1998-03-18 | 2003-01-02 | Mesoblast International Sarl | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
US20030118567A1 (en) | 1999-03-26 | 2003-06-26 | Stewart Duncan John | Cell-based therapy for the pulmonary system |
JP2002510655A (ja) | 1998-04-03 | 2002-04-09 | オシリス セラピューティクス,インコーポレイテッド | 免疫抑制剤としての間葉幹細胞によるt細胞応答を阻害する方法とその利用 |
BR9910251A (pt) | 1998-05-04 | 2001-01-02 | Point Therapeutics Inc | Estimulação hematopoiética |
US6835377B2 (en) | 1998-05-13 | 2004-12-28 | Osiris Therapeutics, Inc. | Osteoarthritis cartilage regeneration |
CA2328425A1 (fr) | 1998-05-22 | 1999-12-02 | Osiris Therapeutics, Inc. | Production de megacaryocytes par co-culture de cellules souches mesenchymateuses humaines au moyen de cellules cd34+ |
EP1082410B1 (fr) | 1998-05-29 | 2007-08-01 | Osiris Therapeutics, Inc. | Cd45 humain + et/ou fibroblaste + cellules mesenchymales humaines |
EP1108011A2 (fr) | 1998-06-08 | 2001-06-20 | Osiris Therapeutics, Inc. | Conservation in vitro de cellules souches hematopo etiques |
US6255112B1 (en) | 1998-06-08 | 2001-07-03 | Osiris Therapeutics, Inc. | Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
US6713245B2 (en) | 1998-07-06 | 2004-03-30 | Diacrin, Inc. | Methods for storing neural cells such that they are suitable for transplantation |
ES2198067T3 (es) | 1998-07-28 | 2004-01-16 | Synthes Ag Chur | Utilizacion de compuestos a base de creatina para tratar las celulas y los tejidos oseos y cartilaginosos. |
US5958767A (en) | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
JP3517359B2 (ja) | 1998-09-14 | 2004-04-12 | テルモ株式会社 | 細胞分離・回収装置および細胞の分離・回収方法 |
CA2345397A1 (fr) | 1998-09-23 | 2000-03-30 | Mount Sinai Hospital | Preparations de cellules trophoblastiques |
EP1129176A4 (fr) | 1998-11-09 | 2002-10-30 | Es Cell Int Pte Ltd | Cellules souches embryonnaires |
DE69937966D1 (de) | 1998-11-12 | 2008-02-21 | Cytomatrix Llc | Produktion lymphoider gewebsspezifischer zellen von hämatopoietischen vorläuferzellen in einem dreidimensionalen system |
US6548299B1 (en) * | 1999-11-12 | 2003-04-15 | Mark J. Pykett | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
US6184035B1 (en) * | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
US6102871A (en) | 1998-11-23 | 2000-08-15 | Coe; Rosemarie O. | Blood collection funnel |
US6328765B1 (en) | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
KR20010101266A (ko) | 1998-12-17 | 2001-11-14 | 프리돌린 클라우스너, 롤란드 비. 보레르 | Jnk 단백질 키나제의 억제제로서의 4-아릴옥신돌 |
US6288089B1 (en) | 1998-12-21 | 2001-09-11 | Michael Zawada | Use of kinase inhibitors for treating neurodegenerative diseases |
WO2000038762A1 (fr) | 1998-12-24 | 2000-07-06 | Biosafe S.A. | Systeme de separation sanguine convenant en particulier pour la concentration de cellules souche hematopoietiques |
CZ20013338A3 (cs) * | 1999-03-18 | 2002-03-13 | Celgene Corporation | Substituované 1-oxo-a l,3-dioxoisoindoliny a jejich pouľití ve farmaceutických prostředcích pro sníľení koncentrací zánětlivých cytokinů |
US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
EP1171006B1 (fr) | 1999-04-16 | 2006-03-29 | Wm. MARSH RICE UNIVERSITY | Poly(propylene fumarate) fonctionnalise et poly(propylene fumarate-co-ethylene glycol) |
IN191359B (fr) | 1999-04-20 | 2003-11-29 | Nat Inst Immunology | |
AU4860900A (en) | 1999-06-02 | 2000-12-18 | Lifebank Services, L.L.C. | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
US6333029B1 (en) | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
US6355699B1 (en) | 1999-06-30 | 2002-03-12 | Ethicon, Inc. | Process for manufacturing biomedical foams |
US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
US7015037B1 (en) * | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US8147824B2 (en) | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
US7119114B1 (en) | 1999-08-19 | 2006-10-10 | Signal Pharmaceuticals, Llc | Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto |
US20040072888A1 (en) * | 1999-08-19 | 2004-04-15 | Bennett Brydon L. | Methods for treating inflammatory conditions or inhibiting JNK |
JP2003508211A (ja) | 1999-09-03 | 2003-03-04 | ザ クリーブランド クリニック ファウンデーション | 環状フローチャネルによる継続的な粒子および分子の分離 |
US6239157B1 (en) | 1999-09-10 | 2001-05-29 | Osiris Therapeutics, Inc. | Inhibition of osteoclastogenesis |
US6685936B2 (en) | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
US6280718B1 (en) | 1999-11-08 | 2001-08-28 | Wisconsin Alumni Reasearch Foundation | Hematopoietic differentiation of human pluripotent embryonic stem cells |
WO2001066698A1 (fr) * | 2000-03-09 | 2001-09-13 | Cryo-Cell International, Inc. | Cellules sanguines du cordon ombilical humain utilisees comme source de tissu neural permettant de reparer le cerveau et la moelle epiniere |
US7211226B2 (en) | 2000-03-09 | 2007-05-01 | Fleetgaurd, Inc. | Catalyst and filter combination |
US20010038836A1 (en) | 2000-04-04 | 2001-11-08 | Matthew During | Application of myeloid-origin cells to the nervous system |
US7282366B2 (en) * | 2000-04-27 | 2007-10-16 | Geron Corporation | Hepatocytes for therapy and drug screening made from embryonic stem cells |
US7442390B2 (en) * | 2000-06-05 | 2008-10-28 | University Of South Florida | Method for enhancing engraftment of cells using mesenchymal progenitor cells |
JP2003535148A (ja) | 2000-06-06 | 2003-11-25 | グラクソ グループ リミテッド | 癌の治療方法 |
US6455306B1 (en) | 2000-06-09 | 2002-09-24 | Transcyte, Inc. | Transfusable oxygenating composition |
US6897231B2 (en) | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
US20050009876A1 (en) * | 2000-07-31 | 2005-01-13 | Bhagwat Shripad S. | Indazole compounds, compositions thereof and methods of treatment therewith |
US7211594B2 (en) | 2000-07-31 | 2007-05-01 | Signal Pharmaceuticals, Llc | Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
US6458810B1 (en) | 2000-11-14 | 2002-10-01 | George Muller | Pharmaceutically active isoindoline derivatives |
WO2002044343A2 (fr) | 2000-11-22 | 2002-06-06 | Geron Corporation | Tolerisation d'allogreffes de cellules souches totipotentes |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US7129242B2 (en) | 2000-12-06 | 2006-10-31 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
US7429599B2 (en) | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
US20080152629A1 (en) | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
KR100915482B1 (ko) | 2000-12-06 | 2009-09-03 | 하리리 로버트 제이 | 태반 줄기 세포의 회수 방법 |
US7122544B2 (en) | 2000-12-06 | 2006-10-17 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
US20030045552A1 (en) * | 2000-12-27 | 2003-03-06 | Robarge Michael J. | Isoindole-imide compounds, compositions, and uses thereof |
US7091353B2 (en) | 2000-12-27 | 2006-08-15 | Celgene Corporation | Isoindole-imide compounds, compositions, and uses thereof |
EP2316919B1 (fr) * | 2001-02-14 | 2015-10-07 | Anthrogenesis Corporation | Placenta post-gravidique de mammifère, son utilisation et céllules souches placentaires correspondantes |
MX348185B (es) | 2001-02-14 | 2017-06-02 | Anthrogenesis Corp | Placenta de mamíferos postparto, su uso y células madres placentales extraídas de ella. |
JP2004529621A (ja) | 2001-02-14 | 2004-09-30 | ティー ファークト,レオ | 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞 |
US6987184B2 (en) | 2001-02-15 | 2006-01-17 | Signal Pharmaceuticals, Llc | Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
US20020132343A1 (en) | 2001-03-19 | 2002-09-19 | Clark Lum | System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation |
US20030044977A1 (en) * | 2001-08-10 | 2003-03-06 | Norio Sakuragawa | Human stem cells originated from human amniotic mesenchymal cell layer |
DE10139783C1 (de) | 2001-08-14 | 2003-04-17 | Transtissue Technologies Gmbh | Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung |
EP1288293A1 (fr) | 2001-08-30 | 2003-03-05 | Norio Sakuragawa | Cellules souches neuronales humaines originaires d'une couche de cellules mesenchymateuses amniotiques humaines |
CN1195055C (zh) | 2001-09-06 | 2005-03-30 | 周胜利 | 从胎盘组织中提取造血干细胞用于建立造血干细胞库的新方法 |
US20030068306A1 (en) * | 2001-09-14 | 2003-04-10 | Dilber Mehmet Sirac | Medium |
US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
ATE438708T1 (de) | 2001-11-15 | 2009-08-15 | Childrens Medical Center | Verfahren zur isolierung, expansion und differenzierung fötaler stammzellen aus chorionzotte, fruchtwasser und plazenta und therapeutische verwendungen davon |
JP3728750B2 (ja) | 2001-11-22 | 2005-12-21 | ニプロ株式会社 | 培養皮膚及びその製造方法 |
US7799324B2 (en) | 2001-12-07 | 2010-09-21 | Geron Corporation | Using undifferentiated embryonic stem cells to control the immune system |
JP3934539B2 (ja) | 2001-12-12 | 2007-06-20 | 独立行政法人科学技術振興機構 | 胎盤等由来の成体又は生後組織の前駆細胞 |
WO2003055989A2 (fr) | 2001-12-21 | 2003-07-10 | Mount Sinai Hospital | Compositions cellulaires et procedes de preparation et d'utilisation associes |
WO2003059272A2 (fr) | 2002-01-14 | 2003-07-24 | Henry Ford Health System | Matieres issues des cellules stromales de la moelle osseuse destinees a la formation de vaisseaux sanguins et a la production de facteurs angiogeniques et trophiques |
WO2003061591A2 (fr) * | 2002-01-22 | 2003-07-31 | Advanced Cell Technology, Inc. | Cellules endotheliales derivees de cellules souches modifiees pour interrompre l'angiogenese des tumeurs |
US20030161818A1 (en) | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
US7736892B2 (en) | 2002-02-25 | 2010-06-15 | Kansas State University Research Foundation | Cultures, products and methods using umbilical cord matrix cells |
AU2003225791A1 (en) | 2002-03-15 | 2003-09-29 | Department Of Veterans Affairs, Rehabilitation R And D Service | Methods and compositions for directing cells to target organs |
US20030187515A1 (en) | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
AU2003262187A1 (en) | 2002-04-12 | 2003-10-27 | Celgene Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
US20050148034A1 (en) | 2002-04-12 | 2005-07-07 | Hariri Robert J. | Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
US7498171B2 (en) | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
CA2483010A1 (fr) | 2002-04-19 | 2003-10-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Cellules souches placentaires et utilisations |
US20040161419A1 (en) | 2002-04-19 | 2004-08-19 | Strom Stephen C. | Placental stem cells and uses thereof |
US20050058641A1 (en) * | 2002-05-22 | 2005-03-17 | Siemionow Maria Z. | Tolerance induction and maintenance in hematopoietic stem cell allografts |
AU2003231950A1 (en) | 2002-05-30 | 2003-12-19 | Celgene Corporation | Modulating cell differentiation and treating myeloproliferative disorders with JNK/MKK inhibitors |
US7422736B2 (en) * | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
ES2560847T3 (es) | 2002-07-31 | 2016-02-23 | Yves Saint-Laurent Parfums | Células madre procedentes de tejido adiposo y células diferenciadas procedentes de estas células |
JP2006509770A (ja) | 2002-11-26 | 2006-03-23 | アンソロジェネシス コーポレーション | 細胞治療学、細胞治療単位、およびそれらを利用した治療法 |
BRPI0407221A (pt) | 2003-02-11 | 2006-01-31 | John E Davies | Extrato de geléia de wharton, método para a obtenção de uma célula progenitora humana, métodos para a produção de uma população de células, populações de células e método para a produção de tecido ósseo |
WO2004071283A2 (fr) | 2003-02-13 | 2004-08-26 | Anthrogenesis Corporation | Utilisation de sang de cordon ombilical pour traiter des individus presentant une maladie, un trouble ou une pathologie |
WO2004087896A2 (fr) | 2003-03-31 | 2004-10-14 | Pfizer Products Inc. | Mise en croissance et differenciation de cellules souches |
CN1548529A (zh) | 2003-05-09 | 2004-11-24 | 中国人民解放军军事医学科学院基础医 | 一种人胎盘间充质干细胞的分离方法 |
JP4950660B2 (ja) * | 2003-06-27 | 2012-06-13 | エチコン、インコーポレイテッド | 分娩後由来細胞を使用する眼組織の修復および再生 |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US7569385B2 (en) | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
US20050089513A1 (en) | 2003-10-28 | 2005-04-28 | Norio Sakuragawa | Side population cells originated from human amnion and their uses |
WO2005047491A2 (fr) | 2003-11-10 | 2005-05-26 | Amgen Inc. | Methodes d'utilisation de cellules de c-kit+ mobilisees par g-cff pour produire des grappes de cellules semblables a un corps embryoide pour la reparation tissulaire et le traitement de la myopathie cardiaque |
KR100560340B1 (ko) | 2003-11-11 | 2006-03-14 | 한훈 | 제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법 |
KR20050047500A (ko) | 2003-11-17 | 2005-05-20 | 오일환 | 중간엽기질세포를 이용한 생착증진 방법 |
EP2065383A1 (fr) | 2003-11-19 | 2009-06-03 | Signal Pharmaceuticals, Inc. | Composés d'indazoles et procédés d'utilisation associés en tant qu'inhibiteurs de kinase de protéine |
JP2005151907A (ja) | 2003-11-27 | 2005-06-16 | Shigeo Saito | 胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法 |
MXPA06006061A (es) | 2003-12-02 | 2006-08-11 | Celgene Corp | Metodos y composiciones para el tratamiento y manejo de la hemoglinopatia y la anemia. |
TWI338714B (en) | 2003-12-02 | 2011-03-11 | Cathay General Hospital | Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid |
US20050176139A1 (en) | 2004-01-12 | 2005-08-11 | Yao-Chang Chen | Placental stem cell and methods thereof |
US20050266391A1 (en) | 2004-01-15 | 2005-12-01 | Bennett Brydon L | Methods for preserving tissue |
EP2298862B1 (fr) | 2004-03-22 | 2017-08-30 | Mesoblast International Sàrl | Cellules souches mésenchymateuses et utilisations associées |
US20080095749A1 (en) | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
WO2005097190A2 (fr) | 2004-03-26 | 2005-10-20 | Celgene Corporation | Systemes et procedes pour produire une banque de cellules souches |
WO2005105992A1 (fr) | 2004-04-21 | 2005-11-10 | New York Eye & Ear Infirmary | Formulations de culture de chondrocytes |
JP2006006249A (ja) | 2004-06-28 | 2006-01-12 | Hiroshima Univ | 羊膜由来細胞の培養方法及びその利用 |
US7244759B2 (en) | 2004-07-28 | 2007-07-17 | Celgene Corporation | Isoindoline compounds and methods of making and using the same |
WO2006015214A2 (fr) | 2004-07-29 | 2006-02-09 | Steenblock Research Institute, Inc. | Composition de cellules souches de cordon ombilical et methode de traitement de maladies neurologiques |
PL1789534T3 (pl) | 2004-08-16 | 2015-03-31 | Cellresearch Corp Pte Ltd | Wyodrębnienie komórek macierzystych/progenitorowych z błony owodniowej pępowiny |
US7909806B2 (en) | 2004-09-23 | 2011-03-22 | Anthrogenesis Corporation | Cord blood and placenta collection kit |
US7147626B2 (en) * | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
US8039258B2 (en) | 2004-09-28 | 2011-10-18 | Ethicon, Inc. | Tissue-engineering scaffolds containing self-assembled-peptide hydrogels |
EP1827422A2 (fr) | 2004-11-23 | 2007-09-05 | Celgene Corporation | Procedes et compositions permettant d'utiliser des inhibiteurs jnk pour traiter et gerer une blessure du systeme nerveux central |
WO2006068809A2 (fr) | 2004-12-03 | 2006-06-29 | New Jersey Institute Of Technology | Reconnaissance de substrat par cellules souches mesenchymateuses humaines differenciables |
WO2006101548A2 (fr) | 2004-12-21 | 2006-09-28 | Ethicon, Inc. | Cellules post-partum derivees du tissu du cordon ombilical et leurs procedes de fabrication, de mise en culture et d'utilisation |
US20060166361A1 (en) | 2004-12-21 | 2006-07-27 | Agnieszka Seyda | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
PL1831356T3 (pl) | 2004-12-23 | 2017-07-31 | DePuy Synthes Products, Inc. | Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania |
AU2005322068B2 (en) | 2004-12-23 | 2011-09-01 | Ethicon Incorporated | Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
WO2006071773A2 (fr) | 2004-12-23 | 2006-07-06 | Ethicon Incoporated | Traitement de maladies osteochondrales utilisant des cellules derivees de post-partum et des produits de ceux-ci |
US7850960B2 (en) | 2004-12-30 | 2010-12-14 | University Of Washington | Methods for regulation of stem cells |
CA2593549C (fr) | 2005-01-07 | 2016-04-26 | Wake Forest University Health Sciences | Regeneration des ilots pancreatiques par traitement des cellules souches du liquide amniotique |
US7642091B2 (en) * | 2005-02-24 | 2010-01-05 | Jau-Nan Lee | Human trophoblast stem cells and use thereof |
US20060222634A1 (en) | 2005-03-31 | 2006-10-05 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
CA2648506A1 (fr) | 2005-04-16 | 2006-10-26 | Axordia Limited | Cellule souche decytotrophoblaste |
US8435787B2 (en) | 2005-05-10 | 2013-05-07 | Rutgers, The State University Of New Jersey | Alginate polyelectrolyte encapsulation of embryonic stem cells |
AU2006202209B2 (en) | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
NZ564563A (en) * | 2005-06-10 | 2011-03-31 | Celgene Corp | Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions |
KR20080026198A (ko) * | 2005-06-30 | 2008-03-24 | 안트로제네시스 코포레이션 | 태반 유도된 콜라겐 바이오패브릭을 사용한 고막의 복원 |
US7928280B2 (en) * | 2005-07-13 | 2011-04-19 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
EP1919365A2 (fr) * | 2005-07-13 | 2008-05-14 | Anthrogenesis Corporation | Obturateur oculaire forme a partir dun tissu biologique a base de collagene derive du placenta |
WO2007011693A2 (fr) * | 2005-07-14 | 2007-01-25 | Medistem Laboratories, Inc. | Compositions de cellules souches derivees du placenta, utilisees dans le traitement de cancers |
WO2007024441A2 (fr) | 2005-08-19 | 2007-03-01 | Bio Regenerate, Inc. | Compositions cellulaires enrichies destines a la combinaison de diverses populations cellulaires a base de cellules souches et de cellules progenitrices, leurs methodes d'utilisation, et methodes de mise en banque privee |
US8071376B2 (en) | 2005-10-13 | 2011-12-06 | Anthrogenesis Corporation | Production of oligodendrocytes from placenta-derived stem cells |
CN100344757C (zh) | 2005-10-18 | 2007-10-24 | 天津昂赛细胞基因工程有限公司 | 人胎盘、脐带间充质干细胞库及其构建方法 |
PL1971681T3 (pl) | 2005-12-16 | 2018-01-31 | Depuy Synthes Products Inc | Kompozycje oraz sposoby do hamowania niepożądanej odpowiedzi immunologicznej w przypadku transplantacji z brakiem zgodności tkankowej |
CN101410511B (zh) | 2005-12-19 | 2015-02-25 | 伊西康公司 | 产后来源的细胞在滚瓶中的体外扩增 |
KR20140146220A (ko) | 2005-12-22 | 2014-12-24 | 제인 에니스 | 동결된 제대조직으로부터 유래하는 생존가능한 세포 |
ES2628129T3 (es) | 2005-12-28 | 2017-08-01 | DePuy Synthes Products, Inc. | Tratamiento de la enfermedad vascular periférica utilizando células derivadas del posparto |
CN101374941A (zh) | 2005-12-29 | 2009-02-25 | 人类起源公司 | 采集和保存胎盘干细胞的改良组合物及其使用方法 |
ZA200804718B (en) | 2005-12-29 | 2010-04-28 | Anthrogenesis Corp | Co-culture of placental stem cells and stem cells from a second source |
US20070253931A1 (en) | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
US9944900B2 (en) | 2006-01-18 | 2018-04-17 | Hemacell Perfusion | Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells |
CN101410125A (zh) | 2006-01-23 | 2009-04-15 | 阿特西斯公司 | 脑损伤和疾病的mapc治疗 |
EP1845154A1 (fr) | 2006-04-12 | 2007-10-17 | RNL Bio Co., Ltd. | Cellules souches multipotentes dérivées de tissu placentaire et agents thérapeutiques cellulaires les comprenant |
CN101501185A (zh) * | 2006-06-09 | 2009-08-05 | 人类起源公司 | 胎盘巢(placental niche)及其培养干细胞的用途 |
US20070287176A1 (en) | 2006-06-13 | 2007-12-13 | Alireza Rezania | Chorionic villus derived cells |
EP2089510B1 (fr) | 2006-06-28 | 2021-02-24 | The University of Medicine and Dentistry of New Jersey | Cellules souches dérivées d'amnios et utilisations de celles-ci |
US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
WO2008021391A1 (fr) * | 2006-08-15 | 2008-02-21 | Anthrogenesis Corporation | Biomatériau à base de cordon ombilical pour usage médical |
WO2008042441A1 (fr) | 2006-10-03 | 2008-04-10 | Anthrogenesis Corporation | Utilisation de biomatériau de cordon ombilical en chirurgie oculaire |
US8071135B2 (en) | 2006-10-04 | 2011-12-06 | Anthrogenesis Corporation | Placental tissue compositions |
JP5769925B2 (ja) | 2006-10-06 | 2015-08-26 | アントフロゲネシス コーポレーション | ヒト胎盤コラーゲン組成物、並びにそれらの製造方法及び使用方法 |
US8562972B2 (en) | 2006-10-23 | 2013-10-22 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
JP5670053B2 (ja) | 2006-11-13 | 2015-02-18 | エシコン・インコーポレイテッドEthicon, Incorporated | マイクロキャリアを使用した、産褥由来の細胞の生体外での拡大 |
CN101657206B (zh) | 2007-02-12 | 2013-07-03 | 人类起源公司 | 利用胎盘干细胞治疗炎性疾病 |
CN101688177A (zh) | 2007-02-12 | 2010-03-31 | 人类起源公司 | 来自贴壁胎盘干细胞的肝细胞和软骨细胞;以及cd34+、cd45-胎盘干细胞富集的细胞群 |
AU2008305516A1 (en) | 2007-09-26 | 2009-04-02 | Anthrogenesis Corporation | Angiogenic cells from human placental perfusate |
CN101878034B (zh) | 2007-09-28 | 2013-11-20 | 细胞基因细胞疗法公司 | 使用人胎盘灌洗液和人来自胎盘的中间体自然杀伤细胞的肿瘤抑制 |
DK2217329T3 (en) | 2007-11-07 | 2018-04-23 | Anthrogenesis Corp | APPLICATION OF NAVLINE BLOOD IN THE TREATMENT OF COMPLIANCES IN CONNECTION WITH PREGNANCY BIRTH |
CA2734237C (fr) * | 2008-08-20 | 2019-07-02 | Anthrogenesis Corporation | Traitement d'un accident vasculaire cerebral a l'aide de cellules placentaires isolees |
KR20200011604A (ko) * | 2008-08-20 | 2020-02-03 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
AU2009283161A1 (en) * | 2008-08-22 | 2010-02-25 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
US8367409B2 (en) | 2008-11-19 | 2013-02-05 | Anthrogenesis Corporation | Amnion derived adherent cells |
AU2009316376B2 (en) | 2008-11-21 | 2015-08-20 | Celularity Inc. | Treatment of diseases, disorders or conditions of the lung using placental cells |
WO2010141654A1 (fr) | 2009-06-05 | 2010-12-09 | Anthrogenesis Corporation | Procédé amélioré de collecte de cellules placentaires |
AR077369A1 (es) | 2009-07-02 | 2011-08-24 | Anthrogenesis Corp | Metodopara producir eritrocitos sin celulas alimentadoras |
-
2008
- 2008-02-12 CN CN200880011754XA patent/CN101657206B/zh active Active
- 2008-02-12 SI SI200831012T patent/SI2120977T1/sl unknown
- 2008-02-12 RS RS20130344A patent/RS52921B/en unknown
- 2008-02-12 PT PT87254587T patent/PT2120977E/pt unknown
- 2008-02-12 KR KR1020157005148A patent/KR20150039214A/ko not_active Application Discontinuation
- 2008-02-12 PL PL08725458T patent/PL2120977T3/pl unknown
- 2008-02-12 EP EP08725458.7A patent/EP2120977B1/fr active Active
- 2008-02-12 EP EP13178020.7A patent/EP2687220A3/fr not_active Withdrawn
- 2008-02-12 ES ES08725458T patent/ES2425181T3/es active Active
- 2008-02-12 NZ NZ578819A patent/NZ578819A/en unknown
- 2008-02-12 MX MX2009008563A patent/MX2009008563A/es active IP Right Grant
- 2008-02-12 DK DK08725458.7T patent/DK2120977T3/da active
- 2008-02-12 US US12/030,161 patent/US8460650B2/en active Active
- 2008-02-12 CN CN2013102336953A patent/CN103356711A/zh active Pending
- 2008-02-12 EP EP13162384.5A patent/EP2630959A1/fr not_active Withdrawn
- 2008-02-12 EP EP16166462.8A patent/EP3103462A1/fr not_active Ceased
- 2008-02-12 EP EP20177748.9A patent/EP3763376A1/fr not_active Withdrawn
- 2008-02-12 ME MEP-2013-92A patent/ME01562B/me unknown
- 2008-02-12 CA CA2677397A patent/CA2677397C/fr active Active
- 2008-02-12 WO PCT/US2008/001831 patent/WO2008100498A2/fr active Application Filing
- 2008-02-12 EP EP14193036.2A patent/EP2915537A3/fr not_active Withdrawn
- 2008-02-12 AU AU2008216749A patent/AU2008216749B2/en active Active
- 2008-02-12 JP JP2009549140A patent/JP5979811B2/ja active Active
- 2008-02-12 NZ NZ612888A patent/NZ612888A/en unknown
- 2008-02-12 CN CN201310233685XA patent/CN103356710A/zh active Pending
- 2008-02-12 KR KR1020097018749A patent/KR101569168B1/ko active IP Right Grant
- 2008-02-12 NZ NZ597779A patent/NZ597779A/xx unknown
- 2008-02-12 MX MX2013009114A patent/MX349225B/es unknown
-
2009
- 2009-07-31 ZA ZA2009/05376A patent/ZA200905376B/en unknown
- 2009-08-11 IL IL200338A patent/IL200338A/en not_active IP Right Cessation
-
2010
- 2010-03-29 HK HK10103211.5A patent/HK1135328A1/xx unknown
- 2010-11-29 ZA ZA2010/08540A patent/ZA201008540B/en unknown
-
2011
- 2011-05-13 US US13/107,778 patent/US8753883B2/en active Active
- 2011-05-13 US US13/107,727 patent/US20110280845A1/en not_active Abandoned
-
2013
- 2013-05-10 US US13/891,732 patent/US8916146B2/en active Active
- 2013-08-12 HR HRP20130765AT patent/HRP20130765T1/hr unknown
- 2013-08-14 CY CY20131100699T patent/CY1114301T1/el unknown
-
2014
- 2014-06-25 IL IL233376A patent/IL233376A/en active IP Right Grant
- 2014-06-25 IL IL233377A patent/IL233377A/en active IP Right Grant
- 2014-07-02 JP JP2014136491A patent/JP2014221790A/ja active Pending
- 2014-11-21 US US14/550,524 patent/US20150190433A1/en not_active Abandoned
-
2016
- 2016-03-07 HK HK16102595.7A patent/HK1214530A1/zh unknown
- 2016-09-21 US US15/271,429 patent/US20170007648A1/en not_active Abandoned
- 2016-10-25 IL IL248463A patent/IL248463A0/en unknown
-
2018
- 2018-10-02 IL IL262075A patent/IL262075B/en unknown
-
2020
- 2020-01-24 US US16/752,326 patent/US11723930B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003068937A2 (fr) * | 2002-02-13 | 2003-08-21 | Anthrogenesis Corporation | Cellules souches de type embryonnaire derivees de placenta mammalien post-partum, utilisations, et procedes de traitement a base de cellules de ce type |
WO2006051538A2 (fr) * | 2004-11-10 | 2006-05-18 | Hadasit Medical Research Services And Development Ltd. | Cellules isolees a partir de plasma, dispositif d'isolation associe et leurs utilisations |
WO2007047468A2 (fr) * | 2005-10-13 | 2007-04-26 | Anthrogenesis Corporation | Immunomodulation realisee avec des cellules souches placentaires |
WO2007079183A2 (fr) * | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Populations de cellules souches placentaires |
WO2007108003A2 (fr) * | 2006-03-23 | 2007-09-27 | Pluristem Ltd. | Procedes de developpement cellulaire et utilisations therapeutiques des cellules et des milieux conditionnes produits de cette maniere |
WO2008036374A2 (fr) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogreffes de cellules souches chez des receveurs non conditionnes |
Non-Patent Citations (7)
Title |
---|
BURT RICHARD K ET AL: "High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease.", BLOOD, vol. 101, no. 5, 1 March 2003 (2003-03-01), pages 2064 - 2066, XP055092069, ISSN: 0006-4971 * |
DEANS ROBERT J ET AL: "Mesenchymal stem cells: Biology and potential clinical uses", EXPERIMENTAL HEMATOLOGY, ELSEVIER INC, US, vol. 28, no. 8, 1 August 2000 (2000-08-01), pages 875 - 884, XP002201188, ISSN: 0301-472X, DOI: 10.1016/S0301-472X(00)00482-3 * |
IGURA K ET AL: "ISOLATION AND CHARACTERIZATION OF MESENCHYMAL PROGENITOR CELLS FROM CHORIONIC VILLI OF HUMAN PLACENTA", CYTOTHERAPY, ISIS MEDICAL MEDIA, OXFORD, GB, vol. 6, no. 6, 1 January 2004 (2004-01-01), pages 543 - 553, XP009072873, ISSN: 1465-3249, DOI: 10.1080/14653240410005366 * |
LE BLANC K ET AL: "Mesenchymal stem cells: properties and role in clinical bone marrow transplantation", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, vol. 18, no. 5, 1 October 2006 (2006-10-01), pages 586 - 591, XP027932823, ISSN: 0952-7915, [retrieved on 20061001] * |
LI CHANG DONG ET AL: "MESENCHYMAL STEM CELLS DERIVED FROM HUMAN PLACENTA SUPPRESS ALLOGENEIC UMBILICAL CORD BLOOD LYMPHOCYTE PROLIFERATION", CELL RESEARCH - XIBAO YANJIU, BEIJING, CN, vol. 15, no. 7, 1 July 2005 (2005-07-01), pages 539 - 547, XP009080356, ISSN: 1001-0602 * |
PALUDAN CASPER ET AL: "IMMUNE SUPPRESSION BY PLACENTA DERIVED ADHERENT CELLS (PDAC) CORRELATE WITH MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND IL-2 SECRETION", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 108, no. 11 PART 2, 1 November 2006 (2006-11-01), pages 48B, XP009084830, ISSN: 0006-4971 * |
ZHANG Y ET AL: "COMPARISON OF MESENCHYMAL STEM CELLS FROM HUMAN PLACENTA AND BONE MARROW", CHINESE MEDICAL JOURNAL / ZHONGHUA YIXUE ZAZHI YINGWEN BAN, CHINESE MEDICAL ASSOCIATION, BEIJING, CN, vol. 117, no. 6, 1 June 2004 (2004-06-01), pages 882 - 887, XP009042592, ISSN: 0366-6999 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2915537A3 (fr) | Traitement de maladies inflammatoires au moyen de cellules souches placentaires | |
PH12020550759A1 (en) | Compositions and methods of use of phorbol esters | |
NZ595938A (en) | Tumor suppression using placental stem cells | |
NZ612132A (en) | Immunomodulation using placental stem cells | |
WO2009154770A3 (fr) | Cellules souches mésenchymateuses, compositions et procédés pour le traitement des lésions du tissu cardiaque | |
WO2006060414A3 (fr) | Compositions et methodes de traitement de l'autisme | |
WO2010106436A3 (fr) | Nouveaux agents anti-inflammatoires | |
WO2008083228A3 (fr) | Compositions et procédés pour le traitement d'inflammations et de maladies auto-immunes | |
NZ712789A (en) | Placental stem cell populations | |
IL189555A0 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
WO2007149861A3 (fr) | Réparation de tissu mou et régénération à l'aide des produits de cellules souches | |
JP2010518812A5 (fr) | ||
WO2006078774A3 (fr) | Regulation de l'autophagie et de la survie cellulaire | |
WO2007112288A3 (fr) | Composition cardiovasculaire et utilisation de ladite composition pour le traitement de la maladie d'alzheimer | |
WO2006133052A3 (fr) | Therapie cellulaire pour la degenerescence oculaire | |
WO2011009848A3 (fr) | Utilisation thérapeutique de probiotiques | |
WO2009007849A3 (fr) | Antagonistes du récepteur de l'il-23 et leurs utilisations | |
EP2314274A3 (fr) | Compositions comprenant un copolymère amphiphile superhydrophile et un épaississant micellaire | |
NZ598464A (en) | Methods and compositions for treatment of pulmonary fibrotic disorders | |
WO2009004629A3 (fr) | Procédé pour réduire les symptômes de consommation d'alcool | |
CA116138S (en) | Floor scrubbing pad | |
MX337195B (es) | Composiciones y metodos para tratar condiciones dermatologicas. | |
WO2007039124A3 (fr) | Compositions contenant du colostrum et de l'acide hyaluronique pour le traitement de la secheresse vaginale | |
MX2020005238A (es) | Compuestos novedosos como inhibidores mpges-1. | |
WO2008002620A3 (fr) | Modèle cellulaire pour pathologie de la maladie d'alzheimer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2687220 Country of ref document: EP Kind code of ref document: P Ref document number: 2630959 Country of ref document: EP Kind code of ref document: P Ref document number: 2120977 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1214530 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160429 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1214530 Country of ref document: HK |